biOasis Technologies Ord Shs V.BTI.H

Saltarelli is in the catbird seat...

[prophetoffactz]

And he's looked under the hood of Biodexa in ways that we wil never be able to.

The asset's clinical and near-clinical assets have markets of $12 billion. It also have multiple platform technolgies with J&J investigating two of them. Armistice Capital and Ladenberg Thalmann are on board. And look at the curret market cap and potential in 18 months alone? WAKE UP!  

Saltarelli is in the catbird seat!

[Boomskid]

Now, that I agree with. Saltarelli. Catbird. Like Sylvester with with Tweetie Bird feathers sticking out of his mouth. I tought I taw a puddy tat! jd

[narmac]

,,No matter what way you cut it,,the BTI management team failed us miserably in pushing this technology forward,,,,however they have had no problem pushing themselves forward these past years. They just keep the musical chairs going where there are plenty of chairs for themselves. The advisory board and the board of directors have even been more of a failure! Something all these PhDs should be

[prophetoffactz]

",,No matter what way you cut it,,the BTI management team failed us miserably in pushing this technology forward,,,,however they have had no problem pushing themselves forward these past years." Saltarelli has a choice with his time in this business given his serial success in biotech. I think BTI's misfortune held him back and was very costly to him given he could have went

[zwerp2000]

absolutely absurd. you can't honestly believe what you post

[narmac]

Saltarelli is excited???,,,,,not from his body language in the webinar,,,,looks like he is sedated,,,,and or going thru the motions for the camera,,,,,no mattter,,he gets paid with no skin in the game and couldnt give a rats behind what comes of any of it,,,,,,he is there only for his name,,isnt it obvious,,,,,he was just as excited when interviewed with Bioasis,,,looked like it was past his bed

[Boomskid]

Unlike Rathjen, narmac, Saltarelli may have had the good graces not to grin and gloat at the funeral, I mean, webinar. As Macbeth said, "False face must hide what the false heart doth know." Maybe Saltarelli is well=practiced at telling us that "It hurts me more than it does you." Nah, not buying into that, Mario.  jd

[Boomskid]

About the very successful Saltarelli, poof states "I think BTI's misfortune held him back and was very costly to him given he could have went elsewhere and succeeded. He looks like a believer in BTI despite the setbacks."   That borders on the ridiculous.   Saltarelli has been "held back," poof says, due to "BTI's misfortune." Bioasis's

[prophetoffactz]

"Saltarelli has been "held back," poof says, due to "BTI's misfortune." Bioasis's "misfortune" has happened under Rathjen and Saltarelli's watch, maybe was even caused by them, if not by malice then at least through incompetence.. BTI's "misfortune" happened because management and the BoD could not, or did not, make a success of the

[zwerp2000]

you continue to bring up the ridiculous and absurd excuse that the biotech market has been horrific lately. that does not excuse the lack of progress by this company for so, so many years. nothing in the clinic. you also fail to mention several years ago we had one of the biggest biotech booms ever. why did this company faulter then? you're just absurd

[Boomskid]

Yes, shareholders did demand that Rathjen avoid dilution. That was 4 years ago. Now, with 6% ownership on the horizon I see 94% dilution, with total loss of control.So, are you saying, poof, that Rathjen acted on shareholder wishes to do this?  Maybe I missed it, but I don't remember Rathjen petitioning the shareholders for help in the last 18 months.  Come on, even 50% dilution

[prophetoffactz]

"Yes, shareholders did demand that Rathjen avoid dilution. That was 4 years ago. Now, with 6% ownership on the horizon I see 94% dilution, with total loss of control.So, are you saying, poof, that Rathjen acted on shareholder wishes to do this?" Being severely undercapitalized can boomerang bigtime. Maybe Rathjen should have said that she will only agree to take the job if shareholders

[Boomskid]

Rathjen failed to capitalize Bioasis by either deals or equity financing that reflected the value and opportunity of xB3. She could not and did not accomplish either. She was, however, able to borrow money with destructive terms that led to an "accretive" strategic sellout. That sellout appears to have taken almost 18 months to affect, time enough to attempt something better for

[G1945V]

"Saltarelli is in the catbird seat", without owning a single common share, according to SEDI. I wonder why. Plenty of granted options though, 1,378,217. G1945V

[Boomskid]

Don't worry about Saltarelli and his 1,378,217 options G1945G. He may very well get a much greater reward from Biodexa, or later from a private player if he follows xB3 wherever it may go. I love poof's comment about Saltarelli, "...he's looked under the hood of Biodexa in ways that we wil never be able to." Poof is stating what I've been saying for 18 months, that